Literature DB >> 27318976

Synthesis and biological evaluation of indole-2-carboxamides bearing photoactivatable functionalities as novel allosteric modulators for the cannabinoid CB1 receptor.

Chang-Jiang Qiao1, Hamed I Ali2, Kwang H Ahn3, Srikanth Kolluru2, Debra A Kendall4, Dai Lu5.   

Abstract

5-Chloro-3-ethyl-N-(4-(piperidin-1-yl)phenethyl)-1H-indole-2-carboxamide (ORG27569, 1) is a prototypical allosteric modulator for the cannabinoid CB1 receptor. Based on this indole-2-carboxamide scaffold, we designed and synthesized novel CB1 allosteric modulators that possess photoactivatable functionalities, which include benzophenone, phenyl azide, aliphatic azide and phenyltrifluoromethyldiazrine. To assess their allosteric effects, the dissociation constant (KB) and allosteric binding cooperativity factor (α) were determined and compared to their parent compounds. Within this series, benzophenone-containing compounds 26 and 27, phenylazide-containing compound 28, and the aliphatic azide containing compound 36b showed allosteric binding parameters (KB and α) comparable to their parent compound 1, 7, 8, and 9, respectively. We further assessed these modulators for their impact on G-protein coupling activity. Interestingly, these compounds exhibited negative allosteric modulator properties in a manner similar to their parent compounds, which antagonize agonist-induced G-protein coupling. These novel CB1 allosteric modulators, possessing photoactivatable functionalities, provide valuable tools for future photo-affinity labeling and mapping the CB1 allosteric binding site(s).
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Allosteric modulator; Cannabinoid receptor; Photoactivatable ligands; Photoaffinity labeling

Mesh:

Substances:

Year:  2016        PMID: 27318976      PMCID: PMC4987248          DOI: 10.1016/j.ejmech.2016.05.044

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  50 in total

Review 1.  Using photolabile ligands in drug discovery and development.

Authors:  G Dormán; G D Prestwich
Journal:  Trends Biotechnol       Date:  2000-02       Impact factor: 19.536

Review 2.  The benzodiazepine binding site of GABAA receptors.

Authors:  E Sigel; A Buhr
Journal:  Trends Pharmacol Sci       Date:  1997-11       Impact factor: 14.819

Review 3.  Pharmacology of cannabinoid CB1 and CB2 receptors.

Authors:  R G Pertwee
Journal:  Pharmacol Ther       Date:  1997       Impact factor: 12.310

4.  A key agonist-induced conformational change in the cannabinoid receptor CB1 is blocked by the allosteric ligand Org 27569.

Authors:  Jonathan F Fay; David L Farrens
Journal:  J Biol Chem       Date:  2012-07-30       Impact factor: 5.157

5.  Alternative one-pot synthesis of (trifluoromethyl)phenyldiazirines from tosyloxime derivatives: application for new synthesis of optically pure diazirinylphenylalanines for photoaffinity labeling.

Authors:  Lei Wang; Yuta Murai; Takuma Yoshida; Akiko Ishida; Katsuyoshi Masuda; Yasuko Sakihama; Yasuyuki Hashidoko; Yasumaru Hatanaka; Makoto Hashimoto
Journal:  Org Lett       Date:  2015-01-14       Impact factor: 6.005

6.  Comprehensive synthesis of photoreactive (3-trifluoromethyl)diazirinyl indole derivatives from 5- and 6- trifluoroacetylindoles for photoaffinity labeling.

Authors:  Yuta Murai; Katsuyoshi Masuda; Yasuko Sakihama; Yasuyuki Hashidoko; Yasumaru Hatanaka; Makoto Hashimoto
Journal:  J Org Chem       Date:  2012-09-20       Impact factor: 4.354

Review 7.  Benzophenone photophores in biochemistry.

Authors:  G Dormán; G D Prestwich
Journal:  Biochemistry       Date:  1994-05-17       Impact factor: 3.162

8.  Profiling two indole-2-carboxamides for allosteric modulation of the CB1 receptor.

Authors:  Kwang H Ahn; Mariam M Mahmoud; Sushma Samala; Dai Lu; Debra A Kendall
Journal:  J Neurochem       Date:  2013-01-07       Impact factor: 5.372

9.  PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats.

Authors:  J G Horswill; U Bali; S Shaaban; J F Keily; P Jeevaratnam; A J Babbs; C Reynet; P Wong Kai In
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

10.  Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor.

Authors:  Fabricio A Pamplona; Juliano Ferreira; Octávio Menezes de Lima; Filipe Silveira Duarte; Allisson Freire Bento; Stefânia Forner; Jardel G Villarinho; Luigi Bellocchio; Luigi Bellochio; Carsten T Wotjak; Raissa Lerner; Krisztina Monory; Beat Lutz; Claudio Canetti; Isabelle Matias; João Batista Calixto; Giovanni Marsicano; Marilia Z P Guimarães; Reinaldo N Takahashi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-12       Impact factor: 11.205

View more
  14 in total

Review 1.  Modulation of CB1 cannabinoid receptor by allosteric ligands: Pharmacology and therapeutic opportunities.

Authors:  Leepakshi Khurana; Ken Mackie; Daniele Piomelli; Debra A Kendall
Journal:  Neuropharmacology       Date:  2017-05-17       Impact factor: 5.250

2.  Assessing Allosteric Modulation of CB1 at the Receptor and Cellular Levels.

Authors:  Caitlin E Scott; Debra A Kendall
Journal:  Methods Enzymol       Date:  2017-07-05       Impact factor: 1.600

Review 3.  Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure.

Authors:  Leigh V Panlilio; Zuzana Justinova
Journal:  Neuropsychopharmacology       Date:  2017-08-28       Impact factor: 7.853

Review 4.  Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor.

Authors:  Thuy Nguyen; Jun-Xu Li; Brian F Thomas; Jenny L Wiley; Terry P Kenakin; Yanan Zhang
Journal:  Med Res Rev       Date:  2016-11-23       Impact factor: 12.944

Review 5.  Selective modulation of the cannabinoid type 1 (CB1) receptor as an emerging platform for the treatment of neuropathic pain.

Authors:  Samuel D Banister; Kaavya Krishna Kumar; Vineet Kumar; Brian K Kobilka; Sanjay V Malhotra
Journal:  Medchemcomm       Date:  2019-03-18       Impact factor: 3.597

6.  Allosteric modulators restore orthosteric agonist binding to mutated CB1 receptors.

Authors:  Rachel Dopart; Debra A Kendall
Journal:  J Pharm Pharmacol       Date:  2019-11-13       Impact factor: 3.765

Review 7.  Allosteric modulators of cannabinoid receptor 1: developing compounds for improved specificity.

Authors:  Rachel Dopart; Dai Lu; Aron H Lichtman; Debra A Kendall
Journal:  Drug Metab Rev       Date:  2018-01-21       Impact factor: 4.518

Review 8.  Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.

Authors:  David R Janero; Ganesh A Thakur
Journal:  Expert Opin Drug Discov       Date:  2016-10-21       Impact factor: 6.098

Review 9.  Covalent cannabinoid receptor ligands - structural insight and selectivity challenges.

Authors:  Ian Liddle; Michelle Glass; Joel D A Tyndall; Andrea J Vernall
Journal:  RSC Med Chem       Date:  2022-04-04

Review 10.  Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts.

Authors:  Eric A Wold; Jianping Chen; Kathryn A Cunningham; Jia Zhou
Journal:  J Med Chem       Date:  2018-08-28       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.